← All medicines
RINVOQ 30 mg prolonged-release tablets
Licence EU/1/19/1404/006-009 · Unknown
- Licence holder
- AbbVie Deutschland GmbH & Co. KG (all products →)
- Active substance
- Upadacitinib Hemihydrate
- Dosage form
- Prolonged-release tablet
- Route of administration
- Oral use
- ATC codes
- L04AA, L04AA44
- First authorised
- 16/12/2019
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.